Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Fierce 50
Special Report
Awards Gala
Awards
CRO Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Trending
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Fierce 50
Special Report
Awards Gala
Awards
CRO Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Praluent
Biotech
Regeneron's Praluent sidekick nabs speedy FDA review
Regeneron has taken a step closer to getting a green light for its experimental high cholesterol drug as the FDA allows a swift review of evicanumab.
Ben Adams
Aug 12, 2020 8:35am
Esperion tees up to launch cholesterol-busting meds—affordably
Jan 14, 2020 8:30am
AHA: MedCo's PCSK9 rival inclisiran hits LDL
Nov 18, 2019 4:47am
Medicines Company's cholesterol buster poised for PCSK9 battle
Sep 25, 2019 10:05am
Clean data tee Medicines Company up for PCSK9 scrap
Sep 3, 2019 8:05am
Sanofi and Regeneron to end antibody R&D pact by year’s end
Aug 3, 2017 8:32am
